Search

everythinglearnresearchcommunity

for

Search:↓

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

A boy with Pachyonychia congenita has a confirmed gene mutation, highlighting the need for a local genetic database in India.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

A cancer patient's hair became permanently curly after treatment with nivolumab.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

Neurosteroid production in the brain may delay seizure onset.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

New compounds may help treat prostate issues without affecting androgen receptors.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.